IL186781A0 - Antitumoral tetrahydro-pyrimidines - Google Patents

Antitumoral tetrahydro-pyrimidines

Info

Publication number
IL186781A0
IL186781A0 IL186781A IL18678107A IL186781A0 IL 186781 A0 IL186781 A0 IL 186781A0 IL 186781 A IL186781 A IL 186781A IL 18678107 A IL18678107 A IL 18678107A IL 186781 A0 IL186781 A0 IL 186781A0
Authority
IL
Israel
Prior art keywords
antitumoral
pyrimidines
tetrahydro
antitumoral tetrahydro
Prior art date
Application number
IL186781A
Other languages
English (en)
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of IL186781A0 publication Critical patent/IL186781A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL186781A 2005-05-03 2007-10-18 Antitumoral tetrahydro-pyrimidines IL186781A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05076037 2005-05-03
PCT/EP2006/004117 WO2006117197A1 (en) 2005-05-03 2006-05-03 Antitumoral tetrahydro-pyrimidines

Publications (1)

Publication Number Publication Date
IL186781A0 true IL186781A0 (en) 2008-02-09

Family

ID=36649783

Family Applications (1)

Application Number Title Priority Date Filing Date
IL186781A IL186781A0 (en) 2005-05-03 2007-10-18 Antitumoral tetrahydro-pyrimidines

Country Status (13)

Country Link
US (1) US20100216817A1 (enExample)
EP (1) EP1879870A1 (enExample)
JP (1) JP2008540362A (enExample)
KR (1) KR20080007640A (enExample)
CN (1) CN101171236A (enExample)
AU (1) AU2006243407A1 (enExample)
CA (1) CA2605784A1 (enExample)
EA (1) EA013160B1 (enExample)
IL (1) IL186781A0 (enExample)
MX (1) MX2007013683A (enExample)
NO (1) NO20076162L (enExample)
NZ (1) NZ563054A (enExample)
WO (1) WO2006117197A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102210868A (zh) * 2011-04-29 2011-10-12 济南环肽医药科技有限公司 四氢嘧啶及其衍生物在制备口服吸收促进剂中的应用
LT3615544T (lt) 2017-04-27 2023-05-10 Pharma Mar S.A. Priešnavikiniai junginiai
CN108120792B (zh) * 2017-12-14 2020-03-24 青海出入境检验检疫局检验检疫综合技术中心 一种四氢嘧啶的高效液相检测及含量测定方法
CN110156697B (zh) * 2019-05-30 2022-05-06 常州沃腾化工科技有限公司 一种1,2-二甲基-1,4,5,6-四氢嘧啶的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2743255A (en) * 1952-12-19 1956-04-24 Petrolite Corp Amine-modified thermoplastic phenolaldehyde resins and method of making same
US4292429A (en) * 1978-03-08 1981-09-29 Ciba-Geigy Corporation Imidazole urea and amido compounds

Also Published As

Publication number Publication date
JP2008540362A (ja) 2008-11-20
KR20080007640A (ko) 2008-01-22
EA013160B1 (ru) 2010-02-26
NZ563054A (en) 2010-09-30
EP1879870A1 (en) 2008-01-23
CN101171236A (zh) 2008-04-30
MX2007013683A (es) 2007-12-03
NO20076162L (no) 2007-11-29
AU2006243407A1 (en) 2006-11-09
CA2605784A1 (en) 2006-11-09
US20100216817A1 (en) 2010-08-26
WO2006117197A1 (en) 2006-11-09
EA200702397A1 (ru) 2008-02-28

Similar Documents

Publication Publication Date Title
DE502006001600D1 (en) Pyrazolylcarboxanilide
DE602006016093D1 (en) Cyanoanthranilamidinsektizide
DE602006009492D1 (en) Fluidmaschinen
GB0624980D0 (en) Modification
ZA200800615B (en) Antitumoral compounds
GB0523098D0 (en) Antitumoral compounds
DE602006015303D1 (en) Lecknachweisflicken
GB0519869D0 (en) Revo-filter
GB0524433D0 (en) Contents-relating arrangements
GB0524251D0 (en) Antitumoral compounds
GB0520292D0 (en) Antitumoral compounds
GB0520279D0 (en) Antitumoral compounds
GB0524165D0 (en) Antitumoral compounds
GB0523164D0 (en) Antitumoral compounds
GB2431102B (en) Vessel-filling arrangements
AU3621P (en) Scacover Scaevola aemula
AU3685P (en) DOW10 Tristaniopsis laurina
HK1117513A (en) Antitumoral tetrahydro-pyrimidines
GB0505943D0 (en) All out
GB0424964D0 (en) Antitumoral compounds
GB0425829D0 (en) Antitumoral compounds
GB0525648D0 (en) Modification
GB0503390D0 (en) Foldio-addon
GB0514975D0 (en) Skyrac/autorack
GB0511135D0 (en) Combi-level